enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dapagliflozin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin

   Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment

3. Weight Loss Injections: What You Need to Know, From ... - AOL

   www.aol.com/lifestyle/weight-loss-injections...

   An FDA-approved weight loss medication, naltrexone-bupropion is generally considered effective and safe to use. You may experience side effects like dizziness, mood changes, trouble sleeping, and ...

4. What to consider before starting the new weight loss medications

   www.aol.com/consider-starting-weight-loss...

   Wen: The FDA-approved versions of semaglutide and tirzepatide for weight loss are called Wegovy and Zepbound. There have been shortages of these drugs, and doctors have sometimes prescribed ...

5. Dapagliflozin/saxagliptin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin/saxagliptin

   AHFS/Drugs.com: Professional Drug Facts: ... is a fixed-dose combination anti-diabetic medication used as an adjunct to diet ... The most common side effects include ...

6. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/lifestyle/medications-fda-approved...

   There are seven FDA-approved weight loss medications currently available. These medications are safe and effective and have minimal side effects.

7. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

8. What you should know about the latest obesity medication ...

   www.aol.com/news/obesity-medication-zepbound...

   They were both first approved to treat type 2 diabetes, and clinical trials also showed that they induced a significant amount of weight loss. Wegovy is already on the market, and Zepbound has ...

9. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   The United States Food and Drug Administration and the European Medicines Agency have approved weight loss medications for adults with either a body-mass index (BMI) of at least 30, or a body-mass index of at least 27 with at least one weight-related comorbidity. This patient population is considered to have sufficiently high baseline health ...